IS THE OCCURRENCE OF GESTATIONAL DIABETES MELLITUS IN PREGNANCIES HIGHER FOLLOWING IN VITRO FERTILIZATION TREATMENT? WHY? A RETROSPECTIVE COHORT STUDY (Retracted article. See vol. 7, pg. 553, 2023)


Akbag N. N. A., ALUŞ TOKAT M., Ozoztuerk S., AVDAL E. Ü., OKYAY R. E., DOĞAN Ö. E.

JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES, sa.1, ss.94-102, 2023 (ESCI) identifier

Özet

Purpose: This study aim to determine the occurrence of gestational diabetes mellitus (GDM) in pregnancies after IVF treatment and to evaluate the factors that reduce this risk.Material and Methods: This retrospective cohort study was conducted using the medical records of pregnant women who conceived following IVF at the in-vitro fertilization center between 2002-2019. The data were obtained from medical records and phone interviews. Univariate and multivariate logistic regression analyses were performed.Results: The incidence of GDM was found to be 16.7%. The regression model indicated that the risk of GDM was 4.57 times higher in the age group 36-40 at conception during the IVF cycle than the age group 31-35 (95% CI = 1.18-17.73, p = .028). Furthermore, women who conceived after the second IVF trial had a risk of GDM 3.464 times higher than those that conceived after their first IVF trial (95% CI = 1.07-11.23, p= .038). Conclusion: As age and number of IVF trials increase in infertile women, the risk of GDM increases after IVF treatment.